Catalog
Information

Rabbivac–B

Attenuated vaccine against rabbit myxomatosis

Rabbivac–B

Attenuated vaccine against rabbit myxomatosis

The vaccine is intended for the prevention of rabbit myxomatosis in a safe zone, as well as in threatened and dysfunctional farms.

The vaccine provides the formation of an immune response in rabbits to myxomatosis 5-9 days after a single application of 12 months.